Influence of ovariectomy on cardiac oxidative stress in a renovascular hypertension model

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 9, 2012, Pages 1229-1234

  Barp, Jaqueline ^a   Sartório, Carmem Luiza ^a   Campos, Cristina ^a   Llesuy, Susana Francisca ^a   Araujo, Alex Sander ^a   Belló Klein, Adriane ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

2 kidney 1 clip; Antioxidant enzymes; Estrogen; Heart; Ovarian hormones; Ovariectomy; Oxidative stress; Renovascular hypertension

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART STRESS; HOMOGENATE; LIPID PEROXIDATION; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION;

ANIMALS; BLOOD PRESSURE; CATALASE; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GLUTATHIONE PEROXIDASE; HYPERTENSION, RENOVASCULAR; LIPID PEROXIDATION; MYOCARDIUM; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84865420084     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-078     Document Type: Article

References (38)

1. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105: 121-126. doi:10.1016/S0076-6879(84)05016-3. PMID:6727660.
2. Agarwal, R., Campbell, R.C., and Warnock, D.G. 2004. Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Semin. Nephrol. 24(2): 101-114. doi:10.1016/j. semnephrol.2003.11.008. PMID:15017522.
3. Amirkhizi, F., Siassi, F., Djalali, M., and Foroushani, A.R. 2010. Assessment of antioxidant enzyme activities in erythrocytes of pre-hypertensive and hypertensive women. J. Res. Med. Sci. 15(5): 270-278. PMID:21526095.
4. Barp, J., Araujo, A.S., Fernandes, T.R., Rigatto, K.V., Llesuy, S., Belló-Klein, A., and Singal, P. 2002. Myocardial antioxidant and oxidative stress changes due to sex hormones. Braz. J. Med. Biol. Res. 35(9): 1075-1081. doi:10.1590/S0100-879X2002000900008.
5. Belló-Klein, A., Bock, P.M., Travacio, M., Senna, S.M., Llesuy, S., Homem de Bittencourt, P.I., et al. 2001. Myocardial oxidative stress and antioxidants in hypertension as a result of nitric oxide synthase inhibition. Cardiovasc. Toxicol. 1(1): 43-50. doi:10. 1385/CT:1:1:43. PMID:12213996.
6. Buege, J.A., and Aust, S.D. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52: 302-310. doi:10.1016/S0076-6879(78) 52032-6. PMID:672633.
7. Elliott, W.J. 2008. Renovascular hypertension: an update. J. Clin. Hypertens. (Greenwich), 10(7): 522-533. doi:10.1111/j.1751-7176.2008.07788.x. PMID:18607138.
8. Evelson, P., Travacio, M., Repetto, M., Escobar, J., Llesuy, S., and Lissi, E.A. 2001. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. 388(2): 261-266. doi:10.1006/abbi.2001.2292. PMID: 11368163.
9. Flohé, L., and Gunzler, W.A. 1984. Assays of glutathione peroxidase. Methods Enzymol. 105: 114-121. doi:10.1016/S0076-6879(84) 05015-1. PMID:6727659.
10. Garovic, V.D., Kane, G.C., and Schwartz, G.L. 2005. Renovascular hypertension: balancing the controversies in diagnosis and treatment. Cleve. Clin. J. Med. 72(12): 1135-1144, 1146-1147. doi:10.3949/ccjm.72.12.1135. PMID:16392728.
11. Goldblatt, H., Lynch, J., Hanzal, R.F., and Summerville, W.W. 1934. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59(3): 347-379. doi:10.1084/jem.59.3.347. PMID:19870251.
12. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., et al.HERS Research Group. 2002. Cardiovascular Disease Outcomes during 6.8 years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA, 288(1): 49-57. doi:10.1001/jama.288.1.49. PMID: 12090862.
13. Hazzard, W.R. 1989. Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. Am. J. Obstet. Gynecol. 161(6): 1847-1853. PMID:2690637.
14. Hernández, I., Delgado, J.L., Díaz, J., Quesada, T., Teruel, M.J., Llanos, M.C., and Carbonell, L.F. 2000. 17b-estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279(5): R1599- R1605. PMID:11049841.
15. Jacob, M.H., da Rocha Janner, D., Jahn, M.P., Kucharski, L.C., Belló-Klein, A., and Ribeiro, M.F. 2009. DHEA effects on myocardial Akt signaling modulation and oxidative stress changes in aged rats. Steroids, 74(13-14): 1045-1050. doi:10.1016/j.steroids.2009. 08.005. PMID:19699218.
16. Jung, O., Schreiber, J.G., Geiger, H., Pedrazzini, T., Busse, R., and Brandes, R.P. 2004. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation, 109(14): 1795-1801. doi:10.1161/01.CIR. 0000124223.00113.A4. PMID:15037533.
17. Kao, M.P.C., Ang, D.S.C., Pall, A., and Struthers, A.D. 2010. Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J. Hum. Hypertens. 24(1): 1-8. doi:10.1038/jhh.2009.70. PMID:19727125.
18. Konyalioglu, S., Durmaz, G., and Yalcin, A. 2007. The potential antioxidant effect of raloxifene treatment: a study on heart, liver and brain cortex of ovariectomized female rats. Cell Biochem. Funct. 25(3): 259-266. doi:10.1002/cbf.1328. PMID:16927419.
19. Lenfant, C., Chobanian, A.V., Jones, D.W., and Roccella, E.J. 2003. 7th report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): Resetting the Hypertension Sails. Hypertension, 41(6): 1178-1179. doi:10.1161/01.HYP.0000075790.33892.AE. PMID: 12756222.
20. Lerman, L.O., Nath, K.A., Rodriguez-Porcel, M., Krier, J.D., Schwartz, R.S., Napoli, C., and Romero, J.C. 2001. Increased oxidative stress in experimental renovascular hypertension. Hypertension, 37(2): 541-546. PMID:11230332.
21. Lissi, E., Salim-Hanna, M., Pascual, C., and del Castillo, M.D. 1995. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic. Biol. Med. 18(2): 153-158. doi:10. 1016/0891-5849(94)00117-3. PMID:7744297.
22. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193(1): 265-275. PMID:14907713.
23. Marklund, S.L. 1985. Oxygen toxicity and protective systems. J. Toxicol. Clin. Toxicol. 23(4-6): 289-298. doi:10.3109/ 15563658508990636. PMID:2997458.
24. Massafra, C., De Felice, C., Gioia, D., and Buonocore, G. 1998. Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle. Clin. Endocrinol. (Oxf.), 49(1): 63-67. doi:10.1046/j.1365-2265.1998.00441.x. PMID:9797848.
25. Matthews, K.A., Meilahn, E., Kuller, L.H., Kelsey, S.F., Caggiula, A. W., and Wing, R.R. 1989. Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 321(10): 641-646. doi:10.1056/ NEJM198909073211004. PMID:2488072.
26. Mendelsohn, M.E., and Karas, R.H. 2005. Molecular and cellular basis of cardiovascular gender differences. Science, 308(5728): 1583-1587. doi:10.1126/science.1112062. PMID:15947175.
27. Mendonça, L. de S., Fernandes-Santos, C., and Mandarim-de-Lacerda, C.A. 2007. Cardiac and aortic structural alterations due to surgically-induced menopause associated with renovascular hypertension in rats. Int. J. Exp. Pathol. 88(4): 301-309. doi:10.1111/j.1365-2613.2007.00546.x. PMID:17696911.
28. Min, L.J., Mogi, M., Li, J.M., Iwanami, J., Iwai, M., and Horiuchi, M. 2005. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ. Res. 97(5): 434-442. doi:10.1161/01.RES.0000180753.63183.95. PMID:16081869.
29. Okuniewski, R., Davis, E.A., Jarrott, B., and Widdop, R.E. 1998. A comparison of the development of renal hypertension in male and female rats. Clin. Sci. (Lond.), 95(4): 445-451. doi:10.1042/ CS19970303. PMID:9748420.
30. Oliveira-Sales, E.B., Dugaich, A.P., Carillo, B.A., Abreu, N.P., Boim, M.A., Martins, P.J., et al. 2008. Oxidative stress contributes to renovascular hypertension. Am. J. Hypertens. 21(1): 98-104. doi:10.1038/ajh.2007.12. PMID:18091751.
31. Persky, A.M., Green, P.S., Stubley, L., Howell, C.O., Zaulyanov, L., Brazeau, G.A., and Simpkins, J.W. 2000. Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc. Soc. Exp. Biol. Med. 223(1): 59-66. doi:10.1046/j.1525-1373.2000.22308.x. PMID:10632962.
32. Rueckschloss, U., Duerrschmidt, N., and Morawietz, H. 2003. NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxid. Redox Signal. 5(2): 171-180. doi:10.1089/ 152308603764816532. PMID:12716477.
33. Ruiz-Larrea, M.B., Martin, C., Martinez, R., Navarro, R., Lacort, M., and Miller, N.J. 2000. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens. Chem. Phys. Lipids, 105(2): 179-188. doi:10. 1016/S0009-3084(00)00120-1. PMID:10823465.
34. Simic, D.V., Mimic-Oka, J., Pljesa-Ercegovac, M., Savic-Radojevic, A., Opacic, M., Matic, D., et al. 2006. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J. Hum. Hypertens. 20(2): 149-155. doi:10.1038/sj.jhh.1001945. PMID: 16341053.
35. Singal, P.K., Petkau, A., Gerrard, J.M., Hrushovetz, S., and Foerster, J. 1988. Free radicals in health and disease. Mol. Cell. Biochem. 84(2): 121-122. doi:10.1007/BF00421045. PMID:3231218.
36. Stramba-Badiale, M., Fox, K.M., Priori, S.G., Collins, P., Daly, C., Graham, I., et al. 2006. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur. Heart J. 27(8): 994-1005. doi:10.1093/eurheartj/ ehi819. PMID:16522654.
37. Suzuki, S., Brown, C.M., and Wise, P.M. 2006. Mechanisms of neuroprotection by estrogen. Endocrine, 29(2): 209-215. doi:10. 1385/ENDO:29:2:209. PMID:16785597.
38. Touyz, R.M. 2004. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension, 44(3): 248-252. doi:10.1161/01.HYP. 0000138070.47616.9d. PMID:15262903.